| Ms Linda Vasdias, CRNA | |
|
218a Sunset Rd, Willingboro, NJ 08046-1110 | |
| (609) 835-3069 | |
| (856) 829-0580 |
| Full Name | Ms Linda Vasdias |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 218a Sunset Rd, Willingboro, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205993912 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NO04924500 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Linda Vasdias, CRNA 700 Us Rt 130 N, Suite 203, Cinnaminson, NJ 08077 Ph: (856) 829-9345 | Ms Linda Vasdias, CRNA 218a Sunset Rd, Willingboro, NJ 08046-1110 Ph: (609) 835-3069 |
News Archive
In a new study from Lund University in Sweden, researchers investigated the risk factors for blood clots, i.e. venous thromboembolism (VTE). The results show a strong correlation between height and VTE risk for both women and men. The risk increases with height.
"President Barack Obama, facing growing resistance among Democrats over his support for taxing health benefits, will confront U.S. labor leaders and House lawmakers this week on the issue."
PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.
› Verified 3 days ago
Mr. Timothy Guito, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-3069 Fax: 856-829-0580 | |
Naomi Boney-santiago, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Ballad Ln, Willingboro, NJ 08046 Phone: 800-950-6066 | |
Oluyemisi Omolara Sokunbi-jones, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18 Endwell Ln, Willingboro, NJ 08046 Phone: 908-338-6015 | |
Jennifer Umek, APN Registered Nurse Medicare: Medicare Enrolled Practice Location: 200 Campbell Dr Ste 101, Willingboro, NJ 08046 Phone: 609-877-8777 | |
Mr. Barry Liimakka, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-2900 Fax: 856-829-0580 | |
Charlise E Cole, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 218a Sunset Rd, Willingboro, NJ 08046 Phone: 609-835-2901 |